RainDance Technologies Announces Commercial Release of its Sequence Enrichment Solution

February 10, 2009
LEXINGTON, MASSACHUSETTS, U.S.A., February 4, 2009 -- RainDance Technologies, Inc., a provider of innovative microdroplet-based solutions for human health and disease research, today announced the commercial release of its Sequence Enrichment Solution for sales in North America.

In an announcement at the 2009 Advances in Genome Biology and Technology Conference (AGBT), the company said it has begun accepting orders for the solution and has started commercial production of the solution's components for shipment during the first quarter.

"This milestone represents the first commercialized application of our exciting RainStormTM microdroplet-based technology platform," said Chris McNary, President and Chief Executive Officer of RainDance Technologies. "It underscores the power of droplet-based biology to increase the depth of understanding about biological problems and increase the pace of biomedical discovery."

The RainDance Sequence Enrichment Solution incorporates RainStorm technology for targeted sequencing applications of the human genome. It will enable the high-resolution analysis of genetic variation between individuals within populations at a level unmatched by current methodologies. The solution dramatically improves sample uniformity and reduces the selection bias typically associated with targeted sequencing.

The Sequence Enrichment Solution consists of the following components:
  • The RDT 1000 system generates picoliter-volume discrete PCR reactions in droplets at the unprecedented rate of 10 million per hour. It amplifies hundreds to thousands of genomic loci with high specificity and uniformity.
  • Custom-Order Content for DNA Primer Libraries will be available that enable the amplification of hundreds to thousands of genomic loci in a single tube. RainDance customers can design and order these libraries specifically for their research applications.
  • Sequence enrichment consumables kits, provide a complete workflow solution for easy implementation in the laboratory.
The company also announced that comprehensive training and support services are available to maximize the operating performance of the solution.

"This commercialization step is the culmination of a rigorous Early Access Partner program that involved some of the world's leading genomic research institutions," said McNary. "These organizations see the potential of our Sequence Enrichment Solution to enhance the performance of their next-generation sequencing platforms and accelerate their discovery process."

RainDance also is presenting a workshop, "Enrichment of Genomic Loci for Targeted Sequencing Applications," at the AGBT Conference on February 6 to explain the application and benefits of its new technology in genomics research.

For sales information, contact info@raindancetech.com or call 781-861-6300. The company said the Sequence Enrichment Solution will be available for purchase in Europe later this year.

About RainDance Technologies, Inc.

RainDance Technologies Inc. is a provider of innovative microdroplet-based solutions for human health and disease research. The speed and simplicity of the company's exciting new technology platform enable researchers to design experiments in ways that were previously unaffordable or unimaginable. The company's RainStormtm technology produces picoliter-volume droplets at a rate of 10 million per hour. Each droplet is the functional equivalent of an individual test tube and can contain a single molecule, reaction, or cell. This versatile technology can adapt proven assays for high-speed workflows with minimized process-induced bias or error.

RainDance's initial application will focus on the targeted sequencing of the human genome â€" one of the fastest-growing segments of the $1 billion DNA sequencing market. This application will enable the high-resolution analysis of genetic variation between individuals and populations at a level unmatched by current methodology.

RainDance was founded in 2004 by scientists from Harvard University; the Medical Research Centre in Cambridge, England and the ESPCI in Paris.

For more information, please visit www.RainDancetech.com.


Membership Deliverables

MassBio Membership gives you:

Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members. 

Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.

MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.

Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.

Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.

Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!

Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.